0000000000401002

AUTHOR

Zev Rosenwaks

showing 5 related works from this author

Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization

2019

AbstractVisual morphology assessment is routinely used for evaluating of embryo quality and selecting human blastocysts for transfer after in vitro fertilization (IVF). However, the assessment produces different results between embryologists and as a result, the success rate of IVF remains low. To overcome uncertainties in embryo quality, multiple embryos are often implanted resulting in undesired multiple pregnancies and complications. Unlike in other imaging fields, human embryology and IVF have not yet leveraged artificial intelligence (AI) for unbiased, automated embryo assessment. We postulated that an AI approach trained on thousands of embryos can reliably predict embryo quality with…

animal structuresmedicine.medical_treatmentmedia_common.quotation_subjectDecision treeMedicine (miscellaneous)Health InformaticsFertilityBiologyMachine learningcomputer.software_genrelcsh:Computer applications to medicine. Medical informaticsArticle03 medical and health sciences0302 clinical medicineHealth Information ManagementImage processingMachine learningmedicineBlastocyst030304 developmental biologymedia_common0303 health sciencesPregnancy030219 obstetrics & reproductive medicineIn vitro fertilisationbusiness.industryDeep learningEmbryomedicine.disease3. Good healthComputer Science Applicationsmedicine.anatomical_structureembryonic structureslcsh:R858-859.7Artificial intelligencebusinesscomputerEmbryo qualityNPJ Digital Medicine
researchProduct

In vitro fertilization and andrology laboratories in 2030

2021

The in vitro fertilization and andrology laboratories are at the center of assisted reproductive technologies and the place where technicians and embryologists manipulate gametes and preimplantation-stage embryos with the goal of achieving the best embryo for transfer. Through the years, these laboratories have seen developments in technique, technology, and testing. The goal of this Views and Interviews series is to bring together the thought leaders in the field and envision what the laboratories will look like in the next 10 years.

AndrologyEngineeringmedicine.medical_specialtyIn vitro fertilisationReproductive Medicinebusiness.industrymedicine.medical_treatmentmedicineReproductive medicineObstetrics and GynecologyReproductive technologybusinessFertility and Sterility
researchProduct

Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.

1988

In an effort to overcome possible interference by endogenous gonadotropin-ovarian hormone dynamics, desensitization of the pituitary gonadotropins by a gonadotropin-releasing hormone agonist (GnRHa) was achieved in 12 women with repeatedly failed attempts at multiple follicular stimulation. Eight women were scheduled for in vitro fertilization (IVF) and embryo transfer (ET), and 4 for gamete intrafallopian transfer (GIFT). Stimulation failure was characterized by premature luteinization, poor estradiol (E2) response, or inadequate follicular growth. The agonist was administered by nasal spray 500 to 600 micrograms/day beginning on days 21 to 23 of the menstrual cycle. A rapid desensitizatio…

AgonistAdultendocrine systemmedicine.medical_specialtyMenotropinsmedicine.drug_classmedia_common.quotation_subjectmedicine.medical_treatmentFertilization in VitroBiologyBuserelinReproductive TechniquesOvulation InductionInternal medicineGonadotropin-releasing hormone agonistFollicular phasemedicineHumansGamete intrafallopian transferMenstrual cyclemedia_commonIn vitro fertilisationObstetrics and GynecologyEmbryo TransferEmbryo transferEndocrinologyReproductive MedicineFemaleMenotropinhormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

In vitro fertilization and andrology laboratory in 2030: expert visions.

2021

The aim of this article is to gather 9 thought leaders and their team members to present their ideas about the future of in vitro fertilization and the andrology laboratory. Although we have seen much progress and innovation in the laboratory over the years, there is still much to come, and this article looks at what these leaders think will be important in the future development of technology and processes in the laboratory.

Automation LaboratoryMaleEngineeringVisionbusiness.industryObstetrics and GynecologyFertilization in VitroClinical Laboratory ServicesHistory 21st CenturyAndrologyReproductive MedicinePregnancyInfertilityHumansFemaleAndrologyDiffusion of InnovationbusinessPolicy MakingForecastingFertility and sterility
researchProduct

Robust Automated Assessment of Human Blastocyst Quality using Deep Learning

2018

AbstractMorphology assessment has become the standard method for evaluation of embryo quality and selecting human blastocysts for transfer inin vitro fertilization(IVF). This process is highly subjective for some embryos and thus prone to human bias. As a result, morphological assessment results may vary extensively between embryologists and in some cases may fail to accurately predict embryo implantation and live birth potential. Here we postulated that an artificial intelligence (AI) approach trained on thousands of embryos can reliably predict embryo quality without human intervention.To test this hypothesis, we implemented an AI approach based on deep neural networks (DNNs). Our approac…

animal structuresComputer sciencemedia_common.quotation_subjectmedicine.medical_treatmentMachine learningcomputer.software_genre03 medical and health sciences0302 clinical medicinemedicineQuality (business)Blastocyst030304 developmental biologymedia_common0303 health sciencesPregnancy030219 obstetrics & reproductive medicineIn vitro fertilisationbusiness.industryDeep learningEmbryomedicine.diseasemedicine.anatomical_structureembryonic structuresArtificial intelligencebusinessLive birthcomputerEmbryo quality
researchProduct